Moreover, another in vitro screen using a panel of different drugs and DLBCL cell lines showed synergistic or additive effects of the BET inhibitor OTX015 when combined with several anti-lymphoma agents [407]. This evidence concerns the gene DNER and diffuse large B-cell lymphoma.